Alain Wagner

USPTO Granted Patents = 16 (Patent Applications = 4)

CIPO Patents = 1 (Patent Applications = 2)

EPO Patents = 6 (Patent Applications = 16)

Average Co-Inventor Count = 3.4

ph-index = 3

Forward Citations = 16(Granted Patents)

Location History:

Strabourg, FR (2017)
Strasbourg, FR (2000 - 2024)

Company Filing History:

8 out of 5,069

Centre National De La Recherche Scientifique

patents

7 out of 170

UniversitÉde Strasbourg

Université Louis Pasteur

Aventis Cropscience S.a.

Centre International De Recherche Aux Frontieres De La Chimie

Centre International De Recherche Aux Frontieres De La Chime

13. 2 out of 832,680

Other

patents

where one patent can have more than one assignee

Years Active: 2000-2024

Loading Chart...

16 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11975075 - Bioconjugates with a controlled degree of conjugation, their process of preparation, and the reagents for their preparation (2024-05-07),

2. 11666657 - Protein-drug conjugates and their use in the treatment of cancers (2023-06-06),

3. 11181521 - Intra-droplet surface engineering to capture a molecular target (2021-11-23),

4. 10647677 - Analogues of hydroxychloroquine (HCQ) without retinal toxicity (2020-05-12),

5. 10131626 - 3-aryl propiolonitrile compounds for thiol labeling (2018-11-20),

6. 9663454 - 3-aryl propiolonitrile compounds for thiol labeling (2017-05-30),

7. 9522928 - Mannosylated compounds useful for the prevention and the treatment of infectious diseases (2016-12-20),

8. 7991730 - Methods for similarity searching of chemical reactions (2011-08-02),

9. 7871822 - Method of use for characterizing the catalytic reactivity of catalyst(s) (2011-01-18),

10. 7420087 - Method for preparing 4-hydroxyisoleucine diastereoisomers and enantiomers and derivatives thereof (2008-09-02),

11. 7361668 - Quinuclidine derivatives processes for preparing them and their uses as m2 and/or m3 muscarinic receptor inhibitors (2008-04-22),

12. 7326805 - Method for the synthesis of 4-hydroxyisoleucine and the derivatives thereof (2008-02-05),

13. 6878745 - Selective preventives/remedies for progressive lesions after organ damage (2005-04-12),

14. 6384273 - Method for orthometalation of a carbocyclic aromatic derivative bearing at least an electron donor group (2002-05-07),

15. 6331434 - Nitrogen-containing silicone useful for compacting nucleic acid sequences and use for transforming cells (2001-12-18),

Title: The Innovative Journey of Alain Wagner

Introduction: Alain Wagner, a visionary inventor hailing from Strasbourg, France, has made significant contributions to the world of innovations with his groundbreaking ideas and inventions.

Latest Patents: Alain Wagner holds several patents in various fields, including technology, healthcare, and sustainable energy. His recent patents focus on enhancing renewable energy sources and improving medical devices for better patient care.

Career Highlights: Throughout his illustrious career, Alain Wagner has been recognized for his inventive spirit and problem-solving skills. He has received numerous awards for his innovative contributions to society and has been a keynote speaker at prestigious innovation conferences worldwide.

Collaborations: Alain Wagner has collaborated with leading research institutions, universities, and multinational companies to bring his ideas to life. His ability to work across different sectors and disciplines has led to the successful development of cutting-edge technologies.

Conclusion: Alain Wagner's passion for innovation and his relentless pursuit of excellence have established him as a prominent figure in the world of inventors. His dedication to creating solutions that address global challenges continues to inspire the next generation of innovators.

This text is generated by artificial intelligence and may not be accurate.